Sucker A - Search Results

1

Genetic and clinico-pathologic analysis of metastatic uveal melanoma.

Griewank KG, van de Nes J, Schilling B, Moll I, Sucker A, Kakavand H, Haydu LE, Asher M, Zimmer L, Hillen U, Thompson JF, Scolyer RA, Schadendorf D, Murali R. Griewank KG, et al. Among authors: sucker a. Mod Pathol. 2014 Feb;27(2):175-83. doi: 10.1038/modpathol.2013.138. Epub 2013 Jul 26. Mod Pathol. 2014. PMID: 23887304 Free article.

2

Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.

Djukanovic D, Hofmann U, Sucker A, Rittgen W, Schadendorf D. Djukanovic D, et al. Among authors: sucker a. Anticancer Res. 2000 May-Jun;20(3B):2203-7. Anticancer Res. 2000. PMID: 10928178

3

Collection of autologous monocytes for dendritic cell vaccination therapy in metastatic melanoma patients.

Nguyen XD, Eichler H, Sucker A, Hofmann U, Schadendorf D, Klüter H. Nguyen XD, et al. Among authors: sucker a. Transfusion. 2002 Apr;42(4):428-32. doi: 10.1046/j.1525-1438.2002.00067.x. Transfusion. 2002. PMID: 12076289

4

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.

Paschen A, Méndez RM, Jimenez P, Sucker A, Ruiz-Cabello F, Song M, Garrido F, Schadendorf D. Paschen A, et al. Among authors: sucker a. Int J Cancer. 2003 Mar 1;103(6):759-67. doi: 10.1002/ijc.10906. Int J Cancer. 2003. PMID: 12516095

5

Lack of clinical efficacy of imatinib in metastatic melanoma.

Ugurel S, Hildenbrand R, Zimpfer A, La Rosée P, Paschka P, Sucker A, Keikavoussi P, Becker JC, Rittgen W, Hochhaus A, Schadendorf D. Ugurel S, et al. Among authors: sucker a. Br J Cancer. 2005 Apr 25;92(8):1398-405. doi: 10.1038/sj.bjc.6602529. Br J Cancer. 2005. PMID: 15846297 Free PMC article. Clinical Trial.

6

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma.

Ugurel S, Bell N, Sucker A, Zimpfer A, Rittgen W, Schadendorf D. Ugurel S, et al. Among authors: sucker a. Int J Cancer. 2005 Dec 10;117(5):825-30. doi: 10.1002/ijc.21073. Int J Cancer. 2005. PMID: 15957165

7

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, Weber BL, Nathanson KL, Phillips DJ, Herlyn M, Schadendorf D, Dummer R. Hoek KS, et al. Among authors: sucker a. Pigment Cell Res. 2006 Aug;19(4):290-302. doi: 10.1111/j.1600-0749.2006.00322.x. Pigment Cell Res. 2006. PMID: 16827748

8

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.

Ugurel S, Thirumaran RK, Bloethner S, Gast A, Sucker A, Mueller-Berghaus J, Rittgen W, Hemminki K, Becker JC, Kumar R, Schadendorf D. Ugurel S, et al. Among authors: sucker a. PLoS One. 2007 Feb 21;2(2):e236. doi: 10.1371/journal.pone.0000236. PLoS One. 2007. PMID: 17311103 Free PMC article.

9

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.

Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A. Schwinn N, et al. Among authors: sucker a. Int J Cancer. 2009 Apr 1;124(7):1594-604. doi: 10.1002/ijc.24098. Int J Cancer. 2009. PMID: 19089914

10

Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma.

Helfrich I, Edler L, Sucker A, Thomas M, Christian S, Schadendorf D, Augustin HG. Helfrich I, et al. Among authors: sucker a. Clin Cancer Res. 2009 Feb 15;15(4):1384-92. doi: 10.1158/1078-0432.CCR-08-1615. Clin Cancer Res. 2009. PMID: 19228739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters